Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Minotaur Global Opportunities Fund Minotaur Capital Management Pty Ltd | “Artrya Limited ($AYA.AX) is an Australian medical technology company developing artificial intelligence software to diagnose coronary artery disease through automated coronary CT angiography analysis. The manager maintains a high-conviction bullish stance and used a steep 42% quarterly drawdown to add to the position. The investment thesis argues that recent selling was an irrational sympathy reaction to an unrelated FDA rejection for a peer's ultrasound tool, and that the market has excessively discounted regulatory timeline delays for Artrya's flagship Flow product. Economically, medical diagnostic software models possess superior unit economics once integrated into clinical workflows, generating high-margin software-as-a-service (SaaS) and fee-per-scan revenue with minimal incremental delivery cost. Artrya maintains robust balance sheet liquidity with A$74 million in cash to fund operations through regulatory review phases. The company's economic moat expands as it secures hospital enterprise integrations, creating high switching costs across clinical healthcare networks. Near-term catalysts include the formal FDA filing of the Flow algorithm, commercial rollout at Cone Health, increasing scan and plaque billing volumes, and growing attach rates at live hospital networks like Tanner. Critical risks to monitor include further regulatory filing deferrals, prolonged FDA review timelines, and slower-than-projected clinical adoption by signed US healthcare systems.” | BULL | Q3 2026 Oct 13, 2026 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
